Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation | Zendy

Christopher P. Can | Zendy; Deepak L. Bhatt | Zendy; Jonas Oldgren | Zendy; Gregory Y.H. Lip | Zendy; Stephen G. Ellis | Zendy; Takeshi Kimura | Zendy; Michael Mæng | Zendy; Béla Merkely | Zendy; Uwe Zeymer | Zendy; Savion Gropper | Zendy; Matias Nordaby | Zendy; Eva Kleine | Zendy; Ruth Harper | Zendy; Jenny Manassie | Zendy; James L. Januzzi | Zendy; Jurriën M. ten Berg | Zendy; Philippe Gabríel Steg | Zendy; Stefan H. Hohnloser | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

Author(s) -

Christopher P. Can,

Deepak L. Bhatt,

Jonas Oldgren,

Gregory Y.H. Lip,

Stephen G. Ellis,

Takeshi Kimura,

Michael Mæng,

Béla Merkely,

Uwe Zeymer,

Savion Gropper,

Matias Nordaby,

Eva Kleine,

Ruth Harper,

Jenny Manassie,

James L. Januzzi,

Jurriën M. ten Berg,

Philippe Gabríel Steg,

Stefan H. Hohnloser

Publication year - 2017

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1708454

Subject(s) - medicine , atrial fibrillation , dabigatran , clopidogrel , ticagrelor , warfarin , percutaneous coronary intervention , conventional pci , myocardial infarction , aspirin , cardiology , antithrombotic , hazard ratio , surgery , anesthesia , confidence interval

Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for patients with atrial fibrillation, but this therapy is associated with a high risk of bleeding.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research